Study Supports Use Of MTWA Test As Predictor Of Sudden Cardiac Death

Cambridge Heart, Inc. (OTCBB-CAMH), announced that results of a PREVENT-SCD trial, presented during a American Heart Association Scientific Sessions in Orlando, Florida, strengthen a worth of a Microvolt T-wave Alternans (MTWA) exam in identifying patients during risk of remarkable cardiac death (SCD).

Seniors Struggle With Drug Costs While Congress Debates Medicare 'Doughnut Hole"

Minnesota Public Radio reports: "Since 2006, comparison citizens have been means to select skeleton for Medicare medication drug coverage, though which coverage contains the opening known as the 'doughnut hole,' the opening which illness caring reform skeleton being debated in Congress would address." "Under the House illness caring bill, Medicare would discharge the opening inside of the decade.

CytRx To Initiate Phase 2 Clinical Trial With INNO-206 In Patients With Advanced Gastric Cancer

CytRx Corporation (NASDAQ: CYTR), the biopharmaceutical company, today announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as the second-line treatment in patients with modernized gastric (stomach) cancer. CytRx President and CEO Steven A.

Sen. Grassley Prods Med Schools About Medical Journal Ghostwriting Practices

"Senator Charles E. Grassley wrote to 10 tip healing schools Tuesday to ask what they are doing about professors who put their names upon ghostwritten articles in healing journals - and because that practice was any different from plagiarism by students," The New York Times reports.

Breast Cancer Campaign: New Breast Cancer Research Funding For Belfast

Individualised radiotherapy diagnosis based upon the person's genetic make up could soon become the reality, according to Breast Cancer Campaign. Professor Kevin Prise from Queen's University Belfast has been awarded the three year project grant by the gift to investigate how genes have been involved in the effectiveness of radiotherapy diagnosis for breast cancer.

Vardenafil: A Potential Drug To Protect Gastric Mucosa

Indomethacin has been proved by epidemiological as well as initial studies to be closely associated with peptic ulcer development. Vardenafil is a potent phosphodiesterase 5 inhibitor as well as its goods upon a gastric mucosa have not been reported. A investigate article published in a World Journal of Gastroenterology addresses this problem. The investigate team, led by Dr.

Linkage Biosciences Unveils LinkSeqTM -- A Revolutionary New Tool For Immunogenetic Testing

Linkage Biosciences, Inc., the privately held molecular diagnostics company, not long ago denounced LinkSeq -- the brand new one-step process for Human Leukocyte Antigen (HLA) testing -- at the annual assembly of the American Society of Histocompatibility as well as Immunogenetics (ASHI) in San Francisco.

Also In Global Health News: Sleeping Sickness; Aid For Philippines; U.S., China In Africa; Polio Eradication In Afghanistan; Ethiopia Famine

Lancet Infectious Diseases Examines Hold-Ups In Implementation Of Sleeping Sickness Therapy Lancet Infectious Diseases Newsdesk examines how despite evidence which the new therapy to treat sleeping sickness, called nifurtimox-eflornithine (NECT) is the step forward in treating the

House Vote On Abortion Amendment Continues To Cause Democratic Divisions

The inclusion in the House health remodel bill of an anti-abortion amendment sponsored by Michigan Democratic Rep. Bart Stupak is causing multiplication and discuss between Democrats.

European Antibiotic Awareness Day

Yesterday (18th Nov 2009) marks a second annual European Antibiotic Awareness Day, determined to highlight a complaint of increasing antibiotic resistance as well as a need for advantageous make use of of antibiotics.